Radiotherapy infrastructure and human resources in Europe - Present status and its implications for 2020DATTA, Niloy Ranjan; SAMIEI, Massoud; BODIS, Stephan et al.European journal of cancer (1990). 2014, Vol 50, Num 15, pp 2735-2743, issn 0959-8049, 9 p.Article

Degradation of PKB/Akt protein by inhibition of the VEGF receptor/ mTOR pathway in endothelial cellsRIESTERER, Oliver; ZINGG, Daniel; HUMMERJOHANN, Jörg et al.Oncogene (Basingstoke). 2004, Vol 23, Num 26, pp 4624-4635, issn 0950-9232, 12 p.Article

Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients : Feasibility and responsiveness to clinical changesRIBI, Karin; BERNHARD, Jürg; STAHEL, Rolf A et al.Lung cancer. 2008, Vol 61, Num 3, pp 398-404, issn 0169-5002, 7 p.Article

Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivoHOFSTETTER, Barbara; VUONG, Van; BROGGINI-TENZER, Angela et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1588-1596, issn 1078-0432, 9 p.Article

Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cellsZINGG, Daniel; RIESTERER, Oliver; FABBRO, Doriano et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5398-5406, issn 0008-5472, 9 p.Article

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)PESCE, Gianfranco A; KLINGBIEL, Dirk; CATHOMAS, Richard et al.European journal of cancer (1990). 2012, Vol 48, Num 3, pp 377-384, issn 0959-8049, 8 p.Article

Novel radiosensitizers for locally advanced epithelial tumors: Inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?RIESTERER, Oliver; TENZER, Angela; ZINGG, Daniel et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 2, pp 361-368, issn 0360-3016, 8 p.Conference Paper

Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance of the cytochrome c-mediated caspase-9 death pathwayROCHA, Sonia; SOENGAS, Maria S; LOWE, Scott W et al.Cell growth and differentiation. 2000, Vol 11, Num 9, pp 491-499, issn 1044-9523Article

Management and costs of treating lung cancer patients in a University HospitalDEDES, Konstantin J; SZUCS, Thomas D; BODIS, Stephan et al.PharmacoEconomics (Auckland). 2004, Vol 22, Num 7, pp 435-444, issn 1170-7690, 10 p.Article

Profiling treatment-specific post-translational modifications in a complex proteome with subtractive substrate phage displayTENZER, Angela; HOFSTETTER, Barbara; SAUSER, Christelle et al.Proteomics (Weinheim. Print). 2004, Vol 4, Num 9, pp 2796-2804, issn 1615-9853, 9 p.Article

Key targets for the execution of radiation-induced tumor cell apoptosis : The role of p53 and caspasesPRUSCHY, Martin; ROCHA, Sonia; ZAUGG, Kathrin et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 2, pp 561-567, issn 0360-3016Conference Paper

Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94)GHADJAR, Pirus; HONG SUN; ZIMMERMANN, Frank et al.Oral oncology (1997). 2013, Vol 49, Num 10, pp 1006-1009, issn 1368-8375, 4 p.Article

Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412ZAUGG, Kathrin; ROCHA, Sonia; RESCH, Hildegard et al.Cancer research (Baltimore). 2001, Vol 61, Num 2, pp 732-738, issn 0008-5472Article

The phosphatidylinositide 3'-kinase/akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase CTENZER, Angela; ZINGG, Daniel; ROCHA, Sonia et al.Cancer research (Baltimore). 2001, Vol 61, Num 22, pp 8203-8210, issn 0008-5472Article